Follow DNDi on LinkedInFollow DNDi on TwitterFollow DNDi on Facebook

ASMQ (Malaria)

 

ASMQ to treat Malaria

Fixed dose combination of Artesunate + Mefloquine

First new malaria treatment made in Latin America,
for Latin America and South East Asia!


  • Launched in 2008
  • Included in the Essential Medicines List (EML) and Essential Medicines List for children (EMLc) of the WHO in 2013
  • Developed by an innovative collaboration between DNDi, Brazil and South-East Asia within the FACT Project Consortium
  • Produced by Farmanguinhos/Fiocruz (Brazilian public pharmaceutical company)
  • The 2-in-1 combination ensures that both drugs are taken together in correct proportions
  • Simple and Adapted Regimen for Children and Adults. As Easy as 1-2-3!
  • Adapted Packaging: 3 years shelf life: the longest shelf life of any FDC for malaria.
  • High compliance and low risk of resistance
  • WHO Prequalification in September 2012
  • Registered in Brazil in 2008, in India in 2011, in Malaysia and Myanmar in 2012, in Tanzania in 2013, and in Vietnam and Niger in 2014
  • Successful South-South technology transfer from Farmanguinhos to Cipla Ltd, India
  • Admission of Farmanguinhos/Fiocruz to the PAHO Strategic Fund in April 2013 will allow procurement by South American national control programs
  • Soon available in other countries in Latin America and Southeast Asia

Download ASMQ brochure, September 2012 [1.9MB]
Download ASMQ scientific document, September 2012 [1.3MB]
Download ASMQ press pack, April 2008 [1.1MB]
Read more about ASMQ project





   ASMQ News

Implementation progress

ASMQ: registered in Niger!

Farmanguinhos/Fiocruz admitted to PAHO Strategic Fund

1'200'000 treatments distributed

Recent Scientific Publications
Malaria Journal, May 2014

Population pharmacokinetics of mefloquine, administered as a fixed-dose combination of artesunate-mefloquine in Indian patients for the treatment of acute uncomplicated Plasmodium falciparum malaria
Malaria Journal, December 2013
Safety, efficacy and population pharmacokinetics of fixed-dose combination of artesunate-mefloquine in the treatment of acute uncomplicated Plasmodium falciparum malaria in India

Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site
is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License